DOCSLIB.ORG

BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available BMJ Open: first published as 10.1136/bmjopen-2017-020745 on 12 September 2018. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 28, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2017-020745 on 12 September 2018. Downloaded from Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV) For peer review only Journal: BMJ Open Manuscript ID bmjopen-2017-020745 Article Type: Protocol Date Submitted by the Author: 31-Dec-2017 Complete List of Authors: Mersiades, Antony; University of Sydney, NHMRC Clinical Trials Centre Tognela, Annette; South Western Sydney Local Health District, Macarthur Cancer Therapy Centre, Campbelltown Hospital Haber, Paul; University of Sydney - Camperdown and Darlington Campus, Discipline of Addiction medicine; Sydney Local Health District, Drug Health Services Stockler, Martin; University of Sydney , NHMRC Clinical Trials Centre; Sydney Local Health District, Dept of Medical Oncology, Concord Cancer Care Centre Lintzeris, Nicholas; South East Sydney Local Health District, The Langton Centre; University of Sydney - Camperdown and Darlington Campus, Discipline of Addiction Medicine http://bmjopen.bmj.com/ Simes, John; University of Sydney, NHMRC Clinical Trials Centre; Chris O'Brien Lifehoue, Dept of Medical Oncology McGregor, Iain; University of Sydney, Lambert Initiative for Cannabinoid Therapeutics Olver, Ian; University of South Australia, Sansom Institute for Health Research Allsop, David; University of Sydney, Lambert Initiative for Cannabinoid Therapeutics Gedye, Craig; Calvary Mater Newcastle, Dept of Medical Oncology on September 28, 2021 by guest. Protected copyright. Kirby, Adrienne; University of Sydney, NHMRC Clinical Trials Centre Morton, Rachael; The University of Sydney, NHMRC Clinical Trials Centre Fox, Peter; Orange Health Service, Central West Cancer Care Centre Clarke, Stephen; North Sydney Local Health District, Dept of Medical Oncology, Royal North Shore Hospital; Kolling Institute of Medical Research Briscoe, Karen; Mid North Coast Local Health District, Mid North Coast Cancer Institute Aghmesheh, Morteza; Illawarra Shoalhaven Local Health District, Illawarra Shoalhaven Cancer and Haematology Network, Wollongong Hospital Wong, Nicole; University of Sydney, NHMRC Clinical Trials Centre Walsh, Anna; University of Sydney, NHMRC Clinical Trials Centre Hahn, Carmel; Chris O'Brien Lifehouse Grimison, Peter; University of Sydney, NHMRC Clinical Trials Centre; Chris O'Brien Lifehouse, Dept of Medical Oncology Cannabis, Cannabidiol, Chemotherapy-induced nausea and vomiting, Keywords: Randomized trial, Antiemetic, Marijuana For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 1 of 12 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2017-020745 on 12 September 2018. Downloaded from 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 For peer review only 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 http://bmjopen.bmj.com/ 34 35 36 37 38 39 40 41 on September 28, 2021 by guest. Protected copyright. 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open Page 2 of 12 BMJ Open: first published as 10.1136/bmjopen-2017-020745 on 12 September 2018. Downloaded from 1 2 3 Oral cannabinoid-rich THC/CBD cannabis extract for secondary 4 5 prevention of chemotherapy-induced nausea and vomiting: a 6 7 study protocol for a pilot and definitive randomised double- 8 blind placebo-controlled trial (CannabisCINV) 9 10 Antony Mersiades 1, Annette Tognela 2, Paul S Haber 3 4, Martin Stockler 1 5 6, Nicholas Lintzeris 3 7, 11 John Simes 1 5, Iain McGregor 8, Ian Olver 9, David J Allsop 8, Craig Gedye 10, Adrienne Kirby 1, 12 Rachael L Morton 1, Peter Fox 11, Stephen Clarke 12 13, Karen Briscoe 14, Morteza Aghmesheh 15, 13 Nicole Wong 1, Anna Walsh 1, Carmel Hahn 5, Peter Grimison 1 5 14 15 16 Author Dr Antony ForJ Mersiades peer review only 17 Co-authors Dr Annette Tognela, Prof Paul S Haber, Prof Martin Stockler, Prof Nicholas Lintzeris, Prof John Simes, Prof Iain McGregor, Prof Ian Olver, Dr David J Allsop, Prof Craig Gedye, Ms Adrienne Kirby, Dr 18 Rachael L Morton, Dr Peter Fox, Prof Stephen Clarke, Dr Karen Briscoe, Dr Morteza Aghmesheh, Ms Nicole 19 Wong, Mrs Anna Walsh, Carmel Hahn, A/Prof Peter Grimison 20 21 Corresponding author 22 Dr Antony J Mersiades 23 NHMRC Clinical Trials Centre, University of Sydney 24 Lifehouse, Level 6, 119-143 Missenden Road, Camperdown, NSW, Australia, 2050 25 Email [email protected] 26 Phone +612 9562 5000 27 Author affiliations 28 1NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia 29 2Macarthur Cancer Therapy Centre, Campbelltown Hospital, NSW, Australia 30 3Discipline of Addiction Medicine, University of Sydney, NSW, Australia 31 4Drug Health Services, Sydney Local Health District, NSW, Australia 32 5Dept of Medical Oncology, Chris O’Brien Lifehouse, NSW, Australia 6Dept of Medical Oncology, Concord Cancer Care Centre, Concord Hospital, NSW, Australia 33 http://bmjopen.bmj.com/ 7 34 Drug and Alcohol Services, South East Sydney Local Health District, NSW, Australia 8Lambert Initiative for Cannabinoid Therapeutics, University of Sydney, NSW, Australia 35 9 36 Sansom Institute for Health Research, University of South Australia, Australia 10Dept of Medical Oncology, Calvary Mater Newcastle, NSW, Australia 37 11Central West Cancer Care Centre, Orange Health Service, NSW, Australia 38 12Dept of Medical Oncology, Royal North Shore Hospital, NSW, Australia 39 13Kolling Institute of Medical Research, NSW, Australia 40 14Mid North Coast Cancer Institute, Coffs Harbour Hospital, NSW, Australia 15 41 Illawarra Shoalhaven Cancer and Haematology Network, Wollongong Hospital, NSW, Australia on September 28, 2021 by guest. Protected copyright. 42 43 Keywords 44 Cannabis, cannabidiol, chemotherapy-induced nausea and vomiting, randomized trial, antiemetic 45 46 Word count - 3672 47 48 49 50 51 52 53 54 55 56 57 58 59 60 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 3 of 12 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2017-020745 on 12 September 2018. Downloaded from 1 2 3 ABSTRACT 4 Introduction Chemotherapy-induced nausea and vomiting (CINV) remains an important issue for patients 5 receiving chemotherapy despite guideline consistent antiemetic therapy. Trials using delta-9- 6 Tetrahydrocannabinol-rich (THC) products demonstrate limited antiemetic effect, significant adverse events, 7 and flawed study design. Trials using cannabinoid-rich (CBD) products demonstrate improved efficacy and psychological adverse event profile. No definitive trials have been conducted to support the use of cannabinoids 8 for this indication, nor has the potential economic impact of incorporating such regimens into the Australian 9 healthcare system been established. CannabisCINV aims to assess the efficacy, safety and cost-effectiveness of 10 adding TN-TC11M, an oral cannabidiol-rich THC/CBD extract to guideline-consistent anti-emetics in the 11 secondary prevention of CINV. 12 Methods and analysis The current multi-centre, 1:1 randomised cross-over, placebo-controlled pilot study will 13 recruit 80 adult patients with any malignancy, experiencing CINV during moderate to highly emetogenic 14 chemotherapy despite guideline consistent antiemetics. Patients receive oral TN-TC11M (2.5/2.5mg) capsules 15 or placebo capsules TDS on day -1 to day 5 of cycle A of chemotherapy, followed by the alternative drug 16 regimen during Cycle B of chemotherapy, and the preferred drug regimen during cycle C. The primary end- point is the proportionFor of subjects peer attaining a completereview response to CINV. only Secondary and tertiary endpoints 17 include regimen tolerability, impact on quality of life and health system resource use. The primary assessment 18 tool is patient diaries, which are filled from day -1 to day 5. A subsequent randomised placebo-controlled 19 parallel phase III trial will recruit a further 250 patients. 20 Ethics and dissemination The protocol was approved by ethics review committees for all participating sites. 21 Results will be disseminated in peer-reviewed journals and at scientific conferences. 22 Trial registration number Pre-results, ACTRN number 12616001036404) 23 24 Strengths and limitations of the study 25 ♦ 26 Largest and most definitive
Load more

Recommended publications
  • City of Orange
    Clifton Grove Orange City Council City of Orange October 2018 Charles Sturt University Orange Campus 14 36 4 37 3 RFS 3 104 76 16 2 13 1 28 10 21 17 9 1 14 48 2 115 41 44 31 Ammerdown 132 Waratah 1 Sports Club 2 16 9 Bletchington 6 11 North Orange 3 SES Shopping Centre 21 15 11 7 Adventure 14 1 Playground 17 520 6 140 1 11 Narrambla 2 Orange Botanic Gardens 38 3 4 2 504 483 461 474 2 18 1 25 38 50 441 24 33 16 16 3 Brendon 34 4 17 2 1 Sturgeon Oval 53 18 419 72 456 5 2 65 18 86 36 70 21 7 38 91 75 45 415 409 7 10 19 14 2 s 33 59 68 15 20 39 3 25 40 29 24 20 432 4 7 18 26 17 25 4 RFS 3 2 1 3 15 29 7 33 1 1 2 20 31 14 38 2 49 32 19 5 42 62 49 387 35 40 1 26 6 37 58 50 115 25 10 2 45 112 29 28 1 5 5 22 25 45 2 93 133 171 11 256 278 37 1 28 12 84 92 136 176 190 34 48 39 38 ELF 194 219 Somerset Park 57 2 7 30 16 381 Environmental 27 408 94 196 9 12 39 Learning 70 48 22 40 53 73 Bletchington Facility 75 77 7 31 108 2 3 9 Oval 2 16 11 4 1 189 66 64 105 21 94 14 3 18 13 s 355 Showground 1 79 3 8 2 35 55 73 131 159 4 80 81 51 1 139 35 2 15 28 54 62 70 100 128 154 Hill Park 83 4 2 8 400 187 391 2 28 3 4 40 186 345 197 28 82 355 376 100 57 91 11 51 3 90 67 194 1 Caravan 48 12 52 64 1 352 Mulholland 193 35 87 20 164 162 217 Park 3 11 1 2 Park 231 2 1 2 95 173 81 117 149 163 199 203 166 1 118 25 2 47 86 202 234 23 170 24 130 152 48 84 31 176 57 173 105 255 7 270 Plowman 6 Hill Park 212 Harold Nicholas Walk Perry 141 Park 47 1 15 Ratcliffe RFS 49 40 Oval 327 Margaret 10 22 2 Paul Park 2 16 344 46 Park 13 16 White 339 29 Coulson 27 1 5 9 25 25 29 1
    [Show full text]
  • School of Rural Health Strategic Plan 2017-22 Contents
    School of Rural Health Strategic plan 2017-22 Contents Strategic intent 4 Goals 5 Strategic goals 2017-22 6 The University of Sydney School of Rural Health 2017–22 Strategic Plan October 2017 The School of Rural Health (SRH) is a rural clinical school of the University of Sydney with campuses in Dubbo and Orange. The SRH was established in 2001 with the dual aims of providing medical education in a rural setting, and addressing rural medical workforce shortages. Students can spend up to one year of their four year degree being taught by health practitioners throughout the Central West and Western NSW. The SRH delivers Stage 3 of the Sydney Medical Program (SMP) at both the Dubbo and Orange Campuses. Recruitment to the rural clinical school takes place during Stage 2 of the SMP. Both Dubbo and Orange are located within the Western NSW Local Health District. Orange (population 40,100) is a large regional centre located approximately 250km west of Sydney. Orange Hospital – also known as Orange Health Service – is a large regional Strategic plan 2017-22 hospital with 520 beds, offering a comprehensive range of specialist medical services. Dubbo is located approximately 145 km to the north-north-west of Orange, and is at the intersection of highways to Sydney, Brisbane, Adelaide and Newcastle. It is the major referral centre for healthcare in central and western NSW, serving a catchment population of 130,000. The facilities of Dubbo Hospital are currently being upgraded including the planned development of an Integrated Cancer Care Centre. On completion, the Dubbo Hospital will provide 240 beds.
    [Show full text]
  • The Integrated Mental Health Atlas of Western New South Wales
    The Integrated Mental Health Atlas of Western New South Wales Commercial in Confidence June 2017 1 THIS PAGE IS INTENTIONALLY LEFT BLANK i Disclaimer Inherent Limitations The Menzies Centre for Health Policy, University of Sydney and ConNetica has prepared this report at the request of Western NSW Primary Health Network (WNSW PHN) in our capacity as consultants and in accordance with the terms and conditions of contract provided by WNSW PHN. The report is solely for the purpose and use of the WNSW PHN (ABN 59 605 922 156). The report has been prepared through a consultancy process using specific methods outlined in the Framework section of this report. The Menzies Centre for Health Policy, University of Sydney and ConNetica have relied upon the information obtained through the consultancy as being accurate. Reasonable efforts have been made to obtain information from service providers across the region. The information, statements, statistics and commentary (together the “information”) contained in this report has been prepared by The Menzies Centre for Health Policy, University of Sydney and ConNetica from publicly available materials, materials provided by WNSW PHN, and various Mental Health and Alcohol and Other Drug service providers. The Menzies Centre for Health Policy, University of Sydney and ConNetica have not undertaken any auditing or other forms of testing to verify accuracy, completeness or reasonableness of the information provided or obtained. Accordingly, whilst the information presented in this report is provided in good faith, The Menzies Centre for Health Policy, University of Sydney and ConNetica can accept no responsibility for any errors or omissions in the information provided by other parties, nor the effect of any such error on our analysis, discussion or recommendations.
    [Show full text]
  • Dubbo Health Service Careers PROSPECTUS Contents
    A move to Dubbo could make all the difference! Dubbo Health Service Careers PROSPECTUS Contents Page 2 Acknowledgement of Country Page 3 Welcome from General Manager, Debbie Bickerton Page 4 Message from the Chief Executive, Scott McLachlan Page 5 Western NSW Local Health District Page 6 History of Dubbo Public Hospital Page 7 Dubbo Health Service overview Contact: Page 8 Dubbo Health Service leadership team and services Debbie Bickerton, General Manager Page 10 Dubbo Health Service Redevelopment Dubbo Health Service, Western NSW Local Health District Page 12 Key partnerships PO Box 739 Page 14 Make a difference Dubbo NSW 2830 Page 16 Super-charge your career T. +61 (02) 6809 6809 Page 18 Live the life you deserve! This work is copyright. It may be reproduced in whole or part for study Page 20 How to apply for a job with us and incentives or training purposes subject Contact:to the inclusion of an acknowledgement of the source. It may not be reproducedDebbie Bickerton, for commercial General usage Manager or sale. Reproduction for purposes otherDubbo than Health those Service,indicated Western above requires NSW Local Health written permission from the WesternDistrict NSW Local Health District. Further copies of this documentPO Boxcan be4061 downloaded from the Western Hear what our team have to say! NSW Local Health District website:Dubbo www.wnswlhd.health.nsw.gov.auNSW 2830 T. +61 (02) 6808 6809 Keep an eye out for the video icons and click to © Western NSW Local Health District, 2019 hear to why a move to Dubbo could make all the Content within this publicationCopyright was accurate 2019.
    [Show full text]
  • The New Normal
    International Clinical Operations Board The New Normal Redesigning Care Around Complex Multimorbid Patients Image Credit: iStock. LEGAL CAVEAT The Advisory Board Company has made efforts to verify the accuracy of the information it provides to members. This report relies on data obtained from many sources, however, and The Advisory Board Company cannot guarantee the accuracy of the information provided or any analysis based thereon. In addition, The Advisory Board Company is not in the business of giving legal, medical, accounting, or other professional advice, and its reports Clinical Operations Board should not be construed as professional advice. In particular, members should not rely on any legal commentary in this report as a basis for action, or assume that any tactics described herein would be permitted by applicable law or appropriate for a given member’s situation. Members are advised to consult with appropriate professionals concerning legal, medical, tax, or accounting issues, before implementing any of these tactics. Neither The Advisory Board Company nor its officers, directors, trustees, employees and agents shall be liable for any claims, Project Directors liabilities, or expenses relating to (a) any errors or omissions in this report, whether caused by The Advisory Board Company or any of its employees or agents, or sources or other third parties, (b) any Lachezar Manasiev, MA recommendation or graded ranking by The Advisory Board Company, or (c) failure of member and its employees and agents Ethan Treanor to abide by the terms set forth herein. The Advisory Board is a registered trademark of The Advisory Board Company in the United States and other countries.
    [Show full text]
  • Orange Health Service Readmission and Returns to Acute Care Following Hospitalisation for Eight Clinical Conditions, July 2015 – June 2018
    Summary Dashboard Orange Health Service Readmission and returns to acute care following hospitalisation for eight clinical conditions, July 2015 – June 2018 Measures that assess how healthcare affects patient outcomes, The RSRR calculation takes into account the volume and such as risk-standardised readmission ratios (RSRR), make a characteristics of adults treated in each hospital (known as the crucial contribution to informing efforts to improve care. They case mix), as different hospitals provide care to patients who may should be looked at alongside other measures and used by be more or less likely to require readmission following discharge. clinicians as a tool to prompt discussion and inform the For each hospital, the RSRR compares the ‘observed’ number of development of quality improvement initiatives. readmissions to any hospital, within 30 days of discharge for a For this report, readmission includes both readmission following specific clinical condition or within 60 days for specified surgical hospital discharge and returns to acute care from non-acute procedures, with the ‘expected’ number of readmissions. The inpatient settings. This allows for fairer comparisons given the expected number of readmissions is calculated based on all range of different arrangements hospitals have in place for non- adults admitted with that condition to any New South Wales acute care. (NSW) hospital. The RSRR differs from other readmission indicators principally The RSRR is a ratio. A ratio of less than 1.0 indicates that because it is risk-adjusted and it takes into account readmission readmission was lower than expected to that hospital, whereas a to any, rather than just the same, hospital.
    [Show full text]
  • Original Research Research Letters
    Journal of Hospital Medicine NO. MAY 2018 5 VOL. 13 www.journalofhospitalmedicine.com An Official Publication of the Society of Hospital Medicine Original Research Reviews Returns to Emergency Department, Observation, When are Oral Antibiotics a Safe and Effective or Inpatient Care Within 30 Days After Choice for Bacterial Bloodstream Infections? Hospitalization in 4 States, 2009 and 2010 An Evidence-Based Narrative Review Versus 2013 and 2014 Andrew J. Hale, et al Teryl K. Nuckols, et al Shorter Versus Longer Courses of Antibiotics EDITORIAL Patient-Centered, Payer-Centered, Volume 13, Number 5, May 2018 Volume for Infection in Hospitalized Patients: or Both? The 30-Day Readmission Metric A Systematic Review and Meta-Analysis Craig A. Umscheid and S. Ryan Greysen Stephanie Royer, et al Caregiver Perspectives on Communication EDITORIAL The Maturing Antibiotic Mantra: During Hospitalization at an Academic Pediatric “Shorter Is Still Better” Institution: A Qualitative Study Brad Spellberg Lauren G. Solan, et al ® EDITORIAL Engaging Families as True Partners Choosing Wisely : Things We Do During Hospitalization For No Reason Alisa Khan, et al Things We Do for No Reason—The “48 Hour Improving Teamwork and Patient Outcomes with Rule-out” for Well-Appearing Febrile Infants Daily Structured Interdisciplinary Bedside Rounds: Carrie Herzke, et al A Multimethod Evaluation Robyn Clay-Williams, et al Clinical Care Conundrum Hospitalist Perspective of Interactions with Scratching Beneath the Surface Medicine Subspecialty Consult Services Michael A. Santos, et al Traci N. Adams, et al Perspectives in Hospital Medicine Research Letters The Harm We Do: The Epidemiology and Clinical Associations The Environmental Impact of Medicine of Portal Vein Thrombosis in Hospitalized Patients Julia Schoen and Vineet Chopra With Cirrhosis: A Nationwide Analysis From the National Inpatient Sample Shawn L.
    [Show full text]
  • Trauma Conference 29 – 30 July 2016 Scientific Program
    SWAN 24 TRAUMA CONFERENCE 29 – 30 JULY 2016 SCIENTIFIC PROGRAM 0 Dear Colleagues, It is with very great pleasure that we once again welcome you to the 24th SWAN Trauma Conference. With another world renowned international faculty from Norway, Canada, Colombia, Estonia and New Zealand and our own national experts in trauma care, this conference promises to be a superb mix of lectures, great debates, interactive case scenarios, key note speeches and Q and A sessions. Our regular SWAN delegates will see that we have undergone some changes in particular with the program and website. This year we have expanded the program with multiple concurrent sessions which gives you the chance to pick and choose what particularly interests you or you may have expertise in. Of course there will still be the major plenary sessions for all to attend and we have brought back our free paper session for all to have a chance at presenting their work and research. This year we will examine quality in trauma care as well as have heated discussions on the controversies and complexities of trauma diagnosis and management including the problems of managing the extremes of age. Our very popular annual great debate will again entertain and provoke and our real life case scenarios will continue to generate great dispute, deliberation and discourse. We will move from the resuscitation room to the intensive care unit and finally to the operating room discussing various demanding aspects of caring for the multiply injured patient. We will also have a session that moves us away from Level one centre care to the rural setting which presents its own enormous challenges.
    [Show full text]
  • Role Delineation Levels of Emergency Medicine May 2021
    Role Delineation Levels of Emergency Medicine May 2021 Consistent with the NSW Health Guide to the Role Delineation of Clinical Services (2019) PAGE i NSW HEALTH Role Delineation Levels of Emergency Medicine: Consistent with the Guide to the Role Delineation of Health Services 2019 Role Delineation Levels of Emergency Medicine: Consistent with the Guide to the Role Delineation of Health Services 2019 NSW HEALTH PAGE i NSW MINISTRY OF HEALTH 1 Reserve Road ST LEONARDS NSW 2065 Tel. (02) 9391 9491 Fax. (02) 9391 9928 health.nsw.gov.au Produced by: Strategic Reform and Planning Branch This work is copyright. It may be reproduced in whole or in part for study training purposes subject to the inclusion of an acknowledgement of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above requires written permission from the NSW Ministry of Health. © NSW Ministry of Health 2021 SHPN (HSP&I) 210437 ISBN 978-1-76081-754-1 Copies of this document can be downloaded from the NSW Health website www.health.nsw.gov.au May 2021 PAGE ii NSW HEALTH Role Delineation Levels of Emergency Medicine: Consistent with the Guide to the Role Delineation of Health Services 2019 Role Delineation of Health Services Role delineation has been applied in NSW This document provides a snapshot of the role to inform strategic service, clinical and capital delineation levels for a number of emergency planning at the local and State level since the medicine services in NSW public hospitals. mid-1980s. The NSW Health Guide to the Role Information within this publication may not be Delineation of Clinical Services 2019 (the Guide) comparable to the Role Delineation Levels of is a planning tool that provides a framework to Emergency Medicine (2014), which was based describe the minimum support services, workforce on the Guide to the Role Delineation of Health and other requirements for clinical services to be Services Third Edition 2002.
    [Show full text]
  • Quality Initiatives 2013 2013 QI Award Winners and Highly Commended
    16th Annual ACHS Quality Improvement Awards Page 2 of 309 Quality Initiatives 2013 2013 QI Award Winners and Highly Commended CLINICAL EXCELLENCE and PATIENT SAFETY – Winner Organisation: Peninsula Health and Austin Health Vic Department Clinical Systems Project Teams Project: Improving Safety, Quality and Efficiency of Care through the Development of an E-MR Judges citations: Good example of collaboration between sites and demonstrates continuous and quantified improvement. CLINICAL EXCELLENCE and PATIENT SAFETY – Highly Commended Organisation: Orange Health Service NSW Department: Medical Unit Project: In Safe Hands – Structured Interdisciplinary Bedside Rounds Organisation: Royal Perth Hospital WA Project: Management of Intoxicated Patients Within a Central Business District Emergency Department NON-CLINICAL SERVICE DELIVERY – Winner Organisation: Monash Health VIC Department: Dietetics and Central Production Kitchen Project: Innovative Improvement to Food Services for Patients with Allergies Judges citations: A simple do-able project. Stood out because it was different. Transferable to other situations NON CLINICAL SERVICE DELIVERY – Highly Commended Organisation: Mater Health Services QLD Department: Mater Education Project: Student Placement Online Tool - SPOT Organisation: WA Country Health Service South West Department: Home Safe Project Team, ICT and Clinical Governance Unit Project: Home Safe Project HEALTHCARE MEASUREMENT – Winner Organisation: Bathurst Health Service NSW Department: Physiotherapy and Surgical Ward Project:
    [Show full text]
  • Australian Poetry Journal
    Australian Volume 4 Poetry Journal Issue 2 Australian Poetry Journal Volume 4 Issue 2 Publishing Information Illustrations & reproductions Australian Poetry Journal Cover: Philip Cordingley, pas de deux [A], 2013, acrylic on 2014 Volume 4, Number 2 canvas, 455 x 457mm, private collection. apj.australianpoetry.org A publication of Australian Poetry Ltd p66: Photograph of Yu Jian by Liu Chang. Courtesy of Simon Patton. Editor: Michael Sharkey Designer: Stuart Geddes p68: Cover of Chinese magazine Today [Jintian]. Courtesy Publications: Bronwyn Lovell & Jessica Friedmann of Simon Patton. Interns: Jessica Hirst, Grace Lovell & Lauren Draper p88: Photograph of Claire Gaskin in her twenties by Australian Poetry is the peak industry body for poetry unattributed photographer. Courtesy of Claire Gaskin. in Australia, with a charter to promote and support Australian poets and poetry locally, regionally, nationally, p110: Photograph of Helen Power, Hobart (192?). and internationally. Joseph Eccles. Inscription on verso: ‘Miss Helen Power. This photograph belonged to Miss Eva Mary Allport’; Australian Poetry Journal is published biannually. Address this, and manuscript poems reproduced by permission editorial correspondence to Level 3 The Wheeler Centre, of the Allport Library and Museum of Fine Arts, Hobart. Little Lonsdale Street, Melbourne, Victoria 3000 or by Catalogue No. AUTAS001125883439. email to [email protected] p140: Man, reading newspaper in the garden All submissions must be accompanied by an entry form (1928), Richard Courtney. State Library of Victoria – available on the APJ website; online submissions are H2009.40/242 strongly preferred. Australian Poetry Ltd attains worldwide first publication Support rights in both printed and digital form for the distribution and promotion of the Australian Poetry Journal as a whole.
    [Show full text]
  • ALLIED to KIDS Issue 35 Allied to Kids Is an Initiative of the NSW Child Health Network
    ALLIED TO KIDS Issue 35 Allied to Kids is an initiative of the NSW Child Health Network. August 2011 The newsletter will be circulated regularly to provide updates and information to support allied health professionals who work with children. Creating a Healthy Eater Inside this issue: Introducing solids to an infant can be a stressful time for parents with anxiety about what foods to offer, how often and when. As clinicians we can often see the repercussions of inappropriate introduction to solids including iron Creating a Healthy 1 Eater deficiency, poor texture transition and fussy eating which can continue through early childhood (and beyond in some instances!). At Orange Health Service, in Farewell 1 regional NSW, collaboration between Child & Family Health and Community Dietetics has led to the development of Creating a Healthy Eater, an education Employment 1 package to make introducing solids as stress free as possible for parents. The Opportunity presentation and resource package focuses upon key considerations for introducing solids including encouraging iron rich foods, texture transition, Speech Pathology in 2 Education feeding environment and food allergies. The program has been successful at the Western NSW Health District Quality Events 3 Awards held in July and will be distributed throughout the Western NSW and Far West NSW Health Districts. Positions Vacant 9 For further information about the program please contact: Alexandra Drobiszewski, Department of Nutrition & Dietetics Orange Health Service, 6369 3300 Farewell to a GESCHN Allied Health Educator Many of you will be very familiar with Maree Doble. Maree commenced in the GESCHN Allied Health Educator role in April 2010.
    [Show full text]